The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database

Basit Öğe Kaydı
dc.authoridCoşkun, Belkıs Nihan/0000-0003-0298-4157
dc.authoridGonullu, Emel/0000-0002-6990-4206
dc.authoridKanıtez, Nilüfer Alpay/0000-0003-1185-5816
dc.authoridkucuksahin, orhan/0000-0003-4530-2304
dc.authoridKaradag, Omer/0000-0002-3443-3117
dc.authorwosidCoşkun, Belkıs Nihan/AAG-7155-2021
dc.authorwosidGonullu, Emel/AAK-7851-2021
dc.authorwosidKanıtez, Nilüfer Alpay/W-7332-2019
dc.authorwosidYağız, Burcu/JQW-5031-2023
dc.authorwosidpehlivan, yavuz/AAG-8227-2021
dc.authorwosidkucuksahin, orhan/GZA-3287-2022
dc.authorwosidKaradag, Omer/I-9042-2013
dc.contributor.authorKanitez, Nilufer Alpay
dc.contributor.authorKiraz, Sedat
dc.contributor.authorDalkilic, Ediz
dc.contributor.authorKimyon, Gezmis
dc.contributor.authorMercan, Ridvan
dc.contributor.authorKaradag, Omer
dc.contributor.authorBes, Cemal
dc.date.accessioned2024-06-12T10:54:38Z
dc.date.available2024-06-12T10:54:38Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The coronavirus disease 2019 pandemic has been resulting in increased hospital occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about going to a hospital even they are able to reach. We aimed to show the effect of the first wave of coronavirus disease 2019 pandemic on the treatment of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or spondyloarthritis. Methods: Patients were divided into three groups as follows: pre-pandemic (Pre-p: starting on biological disease-modifying anti-rheumatic drug therapy for the first time within 6 months before March 11, 2020); post-pandemic A (Post-p A: starting on biological disease-modifying anti-rheumatic drug therapy for the first time within the first 6 months after March 11, 2020); post-pandemic B (Post-p B: starting on biological disease-modifying anti-rheumatic drug therapy for the first time within the second 6 months). Results: The number of rheumatoid arthritis patients in the Post-p A and B groups decreased by 51% and 48%, respectively, as compared to the Pre-p group similar rates of reduction were also determined in the number of spondyloarthritis patients. The rates of tofacitinib and abatacept use increased in rheumatoid arthritis patients in Post-p period. Conclusion: The number of rheumatoid arthritis and spondyloarthritis patients starting on biological disease-modifying anti-rheumatic drugs for the first time decreased during the first year of the coronavirus disease 2019 pandemic.en_US
dc.identifier.doi10.5152/eurjrheum.2022.21153
dc.identifier.endpage211en_US
dc.identifier.issn2147-9720
dc.identifier.issn2148-4279
dc.identifier.issue4en_US
dc.identifier.pmid36650959en_US
dc.identifier.startpage206en_US
dc.identifier.trdizinid1171348en_US
dc.identifier.urihttps://doi.org/10.5152/eurjrheum.2022.21153
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1171348
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19123
dc.identifier.volume9en_US
dc.identifier.wosWOS:000926134500004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEuropean Journal Of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiological Disease-Modifying Anti-Rheumatic Drugen_US
dc.subjectCoronavirus Disease 2019en_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectSpondyloarthritisen_US
dc.subjectSociety Classification Criteriaen_US
dc.subjectBath Ankylosing-Spondylitisen_US
dc.subjectSpondyloarthritisen_US
dc.subjectReliabilityen_US
dc.titleThe First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Databaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu